Why creatine can complicate a kidney blood test, what small trials measured, and what to ask before dismissing an abnormal result.
Creatine supplements can raise blood creatinine and make a creatinine-based kidney-function estimate look lower. That is a reason to interpret the result carefully, not a reason to dismiss an abnormal result. Tell your clinician about the product, amount and timing, and ask how the result compares with previous tests and other kidney findings. National Kidney Foundation explanation.
Evidence checked October 2, 2026. This guide explains the measurements and research limits; it cannot determine whether an individual's kidneys are healthy.
Creatine is the substance supplied by the supplement. Some creatine converts to creatinine, a waste product measured in blood. A common estimated glomerular filtration rate, or eGFR, uses serum creatinine plus other information to estimate kidney filtration.
If creatinine changes for a reason other than filtration, the estimate can shift without an equivalent change in actual kidney function. NKF lists creatine supplements, high muscle mass, cooked meat and recent intense exercise among factors that can raise creatinine independently of kidney health. The size of the effect varies between people. NKF: factors affecting creatinine.
This is different from a claim that the laboratory failed to measure creatinine correctly. The concentration can genuinely be higher while its interpretation as a filtration marker becomes more complicated. Kidney disease can also coexist with supplement use.
Two small trials help explain why the marker and the underlying question need to be separated. Their regimens below describe experiments, not instructions for supplement use.
A 2020 randomized trial assigned healthy men doing resistance training to placebo or 3 or 5 g/day of creatine. Thirty of 36 participants completed it. Within the creatine groups, serum creatinine rose and calculated eGFR fell; between-group comparisons were not significant. Investigators also found no significant between-group differences in the urinary injury markers KIM-1 and MCP-1. Full trial.
The study supports caution about reading creatinine alone as evidence of injury. It did not directly measure GFR, establish safety for everyone or study years of exposure. Participants with a history of kidney disease were excluded.
A 2013 placebo-controlled trial used chromium-51 EDTA clearance to measure GFR in healthy men who lifted weights and ate a high-protein diet. The creatine group used a loading phase followed by maintenance. No significant treatment-by-time difference in measured GFR was found. Original methods and results.
Only 26 of 46 randomized participants were included in the analysis. The authors shortened a planned 12-month study because of withdrawals. Kidney disease and anabolic-steroid use were exclusion criteria. Despite “long-term” in the paper's title, this result covers twelve weeks and should not be presented as proof of lifelong safety or safety during steroid use.
Cystatin C provides another input for estimating filtration. NIDDK generally prefers an equation combining creatinine and cystatin C over creatinine alone, while noting that factors unrelated to filtration can affect either marker. A clinician may choose a different approach for an individual situation. NIDDK adult eGFR guidance.
Even a combined eGFR remains an estimate, not a direct measurement. NIDDK also emphasizes trends over time and urine albumin testing for a fuller assessment in people with or at risk of kidney disease. Cystatin C is therefore a useful question for the appointment, not a home test that automatically overrules every other finding.
Bring the information needed to interpret the result:
Questions to ask include: “Could factors other than filtration influence this result?”, “Would cystatin C, urine testing or a repeat test help?”, and “What preparation should I follow if we repeat it?”
Record the answer before changing your routine. Do not use an internet stopping interval, excessive water intake or other attempts to obtain a better-looking number. The aim is an interpretable result, not a result that hides relevant information.
Ask the ordering clinician. These trials do not establish one washout interval for every product, result or patient. Whether to pause an optional supplement, repeat testing or investigate promptly depends on the clinical situation. Follow any instructions already given, and disclose use even if you have stopped.
Do not delay urgent care while waiting for a supplement washout. If an abnormal result comes with new symptoms, tell the clinical team rather than assuming that training or creatine explains it.
For a separate purchasing decision, our creatine powder and gummy comparison explains labeled amounts, testing and cost. The creatine and hair-loss guide addresses a different safety question. Evidence for one outcome should not be used as a blanket guarantee about another.
Powered by BTST